Valensa Repping NKO for Certain Apps

EUSTIS, Fla. Valensa International signed an agreement with Neptune Technologies & Bioressources Inc. to exclusively incorporate and market the Laval, Quebec-based companys Neptune Krill Oil (NKO®) formulations on a global level for use in condition-specific dietary supplements for joint health and eye health. According to Valensa, the company will develop formulations incorporating the bioavailable omega-3 phospholipids in NKO in conjunction with several of its proprietary ingredients, including Zanthin® Natural Astaxanthin. Valensa has also developed and applied for intellectual property (IP) protection for a range of joint and eye health formulations featuring NKO and other ingredients, and anticipates launch of the products by early 2010.

According to Dr. Rudi E. Moerck, president and CEO of Valensa, NKO is an ideal ingredient for the development of new supplement formulations for the companys signature eye health portfolio as well as the joint health market. In the area of omega-3s, NKO is by far the most effective product from a bioavailability standpoint and NKO is manufactured to quality standards that are in line with Valensas previously stated commitment to the market, he said. Based on the completed clinical trials on NKO to date, and the new trials we are currently conducting, we are excited about the opportunity to work with Neptune Technologies to market and promote truly innovative eye health and joint health formulations.